−Removed: MARKET FOR REGISTRANT’S
−Removed: COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
+Added: MARKET FOR REGISTRANT’S COMMON
+Added: EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Information
8 unchanged sentences
Dividend Policy
−Removed: anticipate that we will retain future earnings for the development, operation and expansion of our business and do not anticipate declaring
−Removed: or paying any cash dividends for the foreseeable future, except that i n March 2023,we agreed with certain investors to modify our
−Removed: dividend policy to state that we intend to pay dividends to all stockholders on a quarterly basis in an amount of which the aggregate
−Removed: of all quarterly dividends shall equal at least seventy-five percent (75%) of our annual net cash flow from operations following the approval
−Removed: of Renazorb by the FDA if obtained, and the commencement of commercial sales.
−Removed: Sales of Unregistered Securities
−Removed: On November 28, 2022, we issued 33,500 shares
−Removed: of restricted common stock to RedChip for investor advisory services.
−Removed: The foregoing issuance was
−Removed: made in a transaction not involving a public offering pursuant to an exemption from the registration requirements of the Securities Act
−Removed: in reliance upon Section 4(a)(2) of the Securities Act or Regulation D promulgated under the Securities Act.
+Added: We currently anticipate that we will retain future
+Added: earnings for the development, operation and expansion of our business and do not anticipate declaring or paying any cash dividends for
+Added: the foreseeable future, except that in March 2023,we agreed with certain investors to modify our dividend policy to state that we intend
+Added: to pay dividends to all stockholders on a quarterly basis in an amount of which the aggregate of all quarterly dividends shall equal
+Added: at least seventy-five percent (75%) of our annual net cash flow from operations following the approval of Oxylanthanum Carbonate by the
+Added: FDA if obtained, and the commencement of commercial sales.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.